Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors-Reference-Cited by-同舟云学术

Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors

Published:2022-03-01 Issue:3 Volume:33 Page:530-540
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Adumeau Pierre¹^ORCID,Raavé René²,Boswinkel Milou²,Heskamp Sandra²^ORCID,Wessels Hans J. C. T.³,van Gool Alain J.³,Moreau Mathieu¹,Bernhard Claire¹,Da Costa Laurène¹^ORCID,Goncalves Victor¹^ORCID,Denat Franck¹

Affiliation:

1. Institut de Chimie Moléculaire de l’Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 Avenue Alain Savary, 21000 Dijon, France

2. Department of Medical Imaging, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands

3. Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands

Funder

Universit? de Bourgogne

Centre National de la Recherche Scientifique

Horizon 2020 Framework Programme

European Social Fund

European Federation of Pharmaceutical Industries and Associations

Conseil r?gional de Bourgogne-Franche-Comt?

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link